Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice-Reference-Cited by-同舟云学术

Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice

Published:2017-12 Issue: Volume:126 Page:138-142
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Scavone Cristina,Rafaniello Concetta,Berrino Liberato,Rossi Francesco,Capuano Annalisa

Publisher

Elsevier BV

Subject

Pharmacology

Reference46 articles.

1. Guideline on Similar Biological Medicinal Products;European Medicine Agency,2014

3. Directive 2001/83/EC, Article 10(2)(b). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf, 2010 (accessed 10 October 2017).

4. Development and regulation of biosimilars: current status and future challenges;Tsiftsoglou;BioDrugs,2013

5. Similar biological medicinal products containing recombinant human growth hormone: european regulation;Pavlovic;Horm. Res.,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of selected serum biomarkers levels in response to the infliximab reference product (Remicade®) versus its biosimilar (Remsima®) in a sample of ulcerative colitis patients: a cross-sectional study;F1000Research;2023-12-06

2. Efficacy and safety analysis of intravitreal bio-similar products of bevacizumab in patients with macular edema because of retinal diseases;Indian Journal of Ophthalmology;2023-05

3. Switching between Originators and Biosimilars in Dermatology: A Systematic Review of Real-World Clinical Studies;Biologics;2023-04-27

4. The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of Biologics;Value in Health;2023-03

5. Pharmacological, Technological, and Digital Innovative Aspects in Rhinology;Frontiers in Allergy;2021-12-15